Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bradley A. Mcgregor, Md

Clinical trials sponsored by Bradley A. Mcgregor, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Triple-Drug cocktail shows promise for rare kidney cancers Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Triple-Drug cocktail shows promise for rare kidney cancers

Disease control Ongoing

This study tests whether combining three drugs (cabozantinib, nivolumab, and ipilimumab) can safely slow or shrink advanced kidney cancers that are not the common clear-cell type. About 60 adults with cancers like papillary or chromophobe RCC that have spread will receive the com…

Phase 2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control

Last updated Jul 25, 2026 00:00 UTC